VisionCare Puts Off FDA Panel Review Of Eye Implant To Collect More Data
This article was originally published in The Gray Sheet
Executive Summary
Cancellation of an FDA panel review of VisionCare Ophthalmic Technologies' IMT implantable miniature telescope, which had been scheduled for April 24, gives the firm time to collect more long-term data